Identification of a Novel Gene for Parkinson Disease
Identification of a Novel Gene for Parkinson Disease
批准号:
8320169
负责人:
Han-Xiang Deng
金额:
$22.88万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-15 至 2013-07-31
关键词:
20pAffectAge of OnsetAlzheimer&aposs DiseaseAmericanAutopsyBiologicalCandidate Disease GeneClinicalCollectionCommunitiesDNADataDisease AssociationDisease ProgressionDopamineEtiologyExhibitsFamilyGenerationsGenesGeneticGenetic HeterogeneityGenetic MaterialsIndividualLeadLewy BodiesLinkMapsMeiosisMolecular TargetMutationNeurodegenerative DisordersParkinson DiseasePathologyPathway interactionsPatientsPenetrancePlayPolymorphic Microsatellite MarkerRecording of previous eventsReplacement TherapyResearchResourcesRoleSamplingTechnologyTestingTherapeuticbasecohortdesigndisease mechanisms studyexomegenetic linkage analysisgenome-wide linkageimprovedkindredlate disease onsetmembernoveloutcome forecastpreventproband
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Parkinson disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease. Although dopamine replacement therapy improves the functional prognosis of PD, there is currently no treatment that prevents the progression of the disease. The etiology of PD is not well understood. Most of the PD cases are sporadic. However, approximately 5-10% of PD patients may have a clear familial history, exhibiting a classical recessive or dominant Mendelian mode of inheritance. Genetic studies in the past more than 10 years have played a vital role in understanding the etiology and pathogenic mechanism of PD. But, the power of genetic study is greatly limited because it requires sufficient number of informative meiosis, i.e. large families with both normal and affected members, especially when great genetic heterogeneity exists. It is particularly a difficult task for most of the late onset neurodegenerative disorders, including PD. Because PD is a late-onset disease with an average age of onset between 60 and 80 years, it is practically rather difficult to collect large PD families and DNA samples. Collection of a large PD family with 2-3 generations normally takes decades. Thus, collection of the large kindreds with PD represents a significant hurdle for identification of new PD-causing genes. Through a 19-year collaborative effort initiated from 1992, we and our collaborators have identified a large PD family with 67 members, among whom 11 members are affected. We have collected clinical information and DNA samples from 62 members, including DNA samples from 10 affected individuals. During this period, two affected and one unaffected members died and were autopsied. Pathological analysis of the two autopsy samples revealed Parkinson pathology, including typical Lewy bodies. But the unaffected member did not show PD pathology. These data suggest that the PD in this kindred is similar to idiopathic PD. Supported by the American Parkinson Disease Association (APDA); we excluded mutations in currently known PD-causing genes, indicating a novel PD locus. We then carried out a genome-wide linkage analysis. The known PD-loci were excluded and a candidate PD-linked locus was suggested on the short arm of chromosome 20. This project is designed to identify a novel PD-causing gene by combined use of the recently developed exome sequencing approach and the unique resources that we have accumulated in the past 19 years. The candidate gene identified in this PD family will be further tested in over 500 familial PD probands. This gene may represent the third gene with a high penetrance for autosomal dominant PD. Completion of this project may not only lead to identification of the genetic basis of PD in this kindred, but also provides the PD research community with a novel molecular target for further studies of the disease mechanisms, biological pathways and potential therapeutic strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a novel therapeutic strategy for treatment of SOD1-linked ALS by CRISPR/Cas9-mediated SOD1 promoter editing
-
批准号:10172990
-
项目类别:
-
资助金额:$37.48万
-
财政年份:2020
-
负责人:Han-Xiang Deng
-
依托单位:
Development of a novel therapeutic strategy for treatment of SOD1-linked ALS by CRISPR/Cas9-mediated SOD1 promoter editing
-
批准号:10409784
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2020
-
负责人:Han-Xiang Deng
-
依托单位:
Mouse model studies of TMEM230-linked Parkinson's disease
-
批准号:9983198
-
项目类别:
-
资助金额:$44.28万
-
财政年份:2016
-
负责人:Han-Xiang Deng
-
依托单位:
Mouse model studies of TMEM230-linked Parkinson's disease
-
批准号:9751106
-
项目类别:
-
资助金额:$44.28万
-
财政年份:2016
-
负责人:Han-Xiang Deng
-
依托单位:
Mouse model studies of TMEM230-linked Parkinson's disease
-
批准号:10532176
-
项目类别:
-
资助金额:$50.01万
-
财政年份:2016
-
负责人:Han-Xiang Deng
-
依托单位:
Mouse model studies of TMEM230-linked Parkinson's disease
-
批准号:10380265
-
项目类别:
-
资助金额:$51.88万
-
财政年份:2016
-
负责人:Han-Xiang Deng
-
依托单位:
Molecular basis of Scapuloperoneal SMA and Charcot-Marie-Tooth disease type 2C
-
批准号:8440280
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2012
-
负责人:Han-Xiang Deng
-
依托单位:
Molecular basis of Scapuloperoneal SMA and Charcot-Marie-Tooth disease type 2C
-
批准号:8850917
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2012
-
负责人:Han-Xiang Deng
-
依托单位:
Molecular basis of Scapuloperoneal SMA and Charcot-Marie-Tooth disease type 2C
-
批准号:8536406
-
项目类别:
-
资助金额:$32.61万
-
财政年份:2012
-
负责人:Han-Xiang Deng
-
依托单位:
Development of mouse models of optineurin-linked ALS
-
批准号:8536975
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2012
-
负责人:Han-Xiang Deng
-
依托单位:
Development of mouse models of optineurin-linked ALS
-
批准号:8428434
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2012
-
负责人:Han-Xiang Deng
-
依托单位:
Molecular basis of Scapuloperoneal SMA and Charcot-Marie-Tooth disease type 2C
-
批准号:8699856
-
项目类别:
-
资助金额:$33.46万
-
财政年份:2012
-
负责人:Han-Xiang Deng
-
依托单位:
Identification of a Novel Gene for Parkinson Disease
-
批准号:8244310
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2011
-
负责人:Han-Xiang Deng
-
依托单位:
Transgenic Study of ALS-Linked CCS Mutations
-
批准号:8152133
-
项目类别:
-
资助金额:$18.68万
-
财政年份:2010
-
负责人:Han-Xiang Deng
-
依托单位:
Transgenic Study of ALS-Linked CCS Mutations
-
批准号:8048792
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2010
-
负责人:Han-Xiang Deng
-
依托单位:
TRANSGENIC STUDIES OF AMYOTROPHIC LATERAL SCLEROSIS
-
批准号:6722891
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2001
-
负责人:Han-Xiang Deng
-
依托单位:
TRANSGENIC STUDIES OF AMYOTROPHIC LATERAL SCLEROSIS
-
批准号:6540289
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2001
-
负责人:Han-Xiang Deng
-
依托单位:
TRANSGENIC STUDIES OF AMYOTROPHIC LATERAL SCLEROSIS
-
批准号:6331616
-
项目类别:
-
资助金额:$32.73万
-
财政年份:2001
-
负责人:Han-Xiang Deng
-
依托单位:
TRANSGENIC STUDIES OF AMYOTROPHIC LATERAL SCLEROSIS
-
批准号:6639663
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2001
-
负责人:Han-Xiang Deng
-
依托单位:
海外基金